PFKFB3 and neoplasm: Accordingly, PFKFB3 downregulation has been shown to decrease the metastatic capacity of cancer cells by reducing vascular permeability through the tightening of VE-Cadherin-mediated endothelial junctions without affecting tumour growth [137].